GSA CAPITAL PARTNERS LLP - PHIO PHARMACEUTICALS CORP ownership

PHIO PHARMACEUTICALS CORP's ticker is PHIO and the CUSIP is 71880W303. A total of 12 filers reported holding PHIO PHARMACEUTICALS CORP in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of PHIO PHARMACEUTICALS CORP
ValueSharesWeighting
Q1 2021$355,000
+30.0%
132,333
+30.5%
0.06%
+31.1%
Q4 2020$273,000
+493.5%
101,401
+376.6%
0.04%
+462.5%
Q3 2020$46,00021,2780.01%
Other shareholders
PHIO PHARMACEUTICALS CORP shareholders Q3 2020
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 40,684$83,0000.01%
Virtu Financial LLC 45,458$92,0000.01%
Total Clarity Wealth Management, Inc. 1,500$3,0000.00%
TWO SIGMA ADVISERS, LP 153,100$311,0000.00%
Cetera Investment Advisers 30,000$61,0000.00%
UBS Group AG 6,241$13,0000.00%
TWO SIGMA INVESTMENTS, LP 42,137$86,0000.00%
BANK OF AMERICA CORP /DE/ 63$00.00%
WELLS FARGO & COMPANY/MN 53$00.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of PHIO PHARMACEUTICALS CORP shareholders